Business Of Biotech

Strategic Deals with CinRx's Gavin Samuels, M.D.

Mar 18, 2024

Dr. Gavin Samuels shares his journey from intensive care physician to CINRX, discussing strategic deals, healthcare innovation, and alternative obesity treatments. The podcast explores efficient biotech services, successful professional attributes, and the importance of collaboration in the industry.

47:52

Episode guests

Gavin Samuels

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Dr. Samuels emphasizes the importance of finding the right company size and culture fit for career satisfaction in the biotech industry.

Patient outcomes should be prioritized in biotech transactions, fostering collaborative negotiations for mutually beneficial deals.

Deep dives

Dr. Gavin Samuels' Career Journey and Career Choices

Dr. Gavin Samuels, the chief business officer at CINRX, discusses his career shift from intensive care physician to industry. Moving away from big biopharma to find a balance in a more innovative, nimble biotech company like CINRX, he highlights the importance of career education in both large and small organizations. By sharing his experience transitioning between different work environments, he emphasizes the significance of finding the right fit in a company's size and culture.

Introduction

2min

Contrasting Large Pharma and Small Biotech Environments for Drug Development

4min

Navigating Healthcare Innovation and Business Strategy

19min

Exploring Alternative Treatments for Obesity

9min

Navigating Biotech Transactions with Strategic Precision

8min

Innovative Efficiency in Biotech and Pharma Services Model

3min

Characteristics of Successful Professionals and Podcast Wrap-Up

1min

We love to hear from our listeners. Send us a message.

Gavin Samuels, M.D. found his work as an intensive care physician boring. After earning his M.D., he did that for a few years before moving into intensive care management roles. It wasn't until he left the hospital and entered biopharma that he found his footing, cutting his teeth in business development at places like Merck, Pfizer, Quark Pharma, and Teva. He even headed growth strategy at Lonza for a while. Now, he's Chief Business Officer and General Partner at CinRx Pharma, where a deep pipeline of early- to late-stage candidates keeps him on his dealmaking toes. Within minutes of our conversation, Dr. Sameuls' introspective reflections on biotech dealmaking and negotiations planted this episode firmly on the Business of Biotech podcast highlight reel.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Business Of Biotech

Strategic Deals with CinRx's Gavin Samuels, M.D.

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

Deep dives

Dr. Gavin Samuels' Career Journey and Career Choices

Factors Influencing Career Decisions in Biotech Industry

Balancing Patient Focus and Collaboration in Biotech Transactions

Cenarix's Efficient Holding Company Model for Drug Development

Remember Everything You Learn from Podcasts